ArticleCentral European journal of urology2024
Expression and activity of matrilysins - matrix metalloproteinases 7 and 26 in human urinary bladder cancer.
Article in Central European journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer: Diagnostic and Prognostic Perspectives: Narrative Review.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Urinary bladder cancer occurs mainly in the elderly and is the fourth most common cancer in humans. The process of metastasis depends on the degradation of the extracellular matrix. The cleavage of its constituent proteins is initiated and prolonged by matrix metalloproteinases (MMPs) present in both pathological and normal tissues, i.e. MMP-7 and MMP-26, which belong to the matrilysin group. The study aimed to evaluate the expression and activity of both MMPs present at different stages of human bladder cancer. Material and methods: We used western blot and ELISA to determine the expression and content of both MMPs in two different types of tissue: healthy and bladder cancer tissue. The fluorimetric method was used to measure the activity (specific and actual) of the enzymes in the tissues. Results: The content of MMP-7 and MMP-26 was very similar in all tested tissues. Their activities differed in both grades of bladder cancer. In all tested tissues, the specific activity of MMP-7 was significantly higher than that of MMP-26. Conclusions: The determined differences in the activities of the two matrilysins demonstrate their opposing involvement in different phases of extracellular matrix remodeling and at different stages of tumour development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.